Chemotherapy Alone for Early Hodgkin's Lymphoma: An Emerging Option
- 20 July 2005
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (21), 4574-4576
- https://doi.org/10.1200/jco.2005.01.911
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective studyAnnals of Oncology, 2004
- Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin diseaseBlood, 2004
- Hodgkin disease: the sword of Damocles resheathedBlood, 2004
- Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiationBlood, 2004
- ABVD Plus Subtotal Nodal Versus Involved-Field Radiotherapy in Early-Stage Hodgkin's Disease: Long-Term ResultsJournal of Clinical Oncology, 2004
- Chemotherapy or Combined Modality Treatment: The Optimal Treatment for Hodgkin's DiseaseJournal of Clinical Oncology, 2004
- Consolidation Radiation After Complete Remission in Hodgkin's Disease Following Six Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Chemotherapy: Is There a Need?Journal of Clinical Oncology, 2004
- Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study GroupJournal of Clinical Oncology, 2003
- Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factorsBlood, 2002
- Poster sessionsAnnals of Oncology, 1996